These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 7076015

  • 1. Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.
    Meredith TJ, Williams GV, Maton PN, Murphy GM, Saxton HM, Dowling RH.
    Gut; 1982 May; 23(5):382-9. PubMed ID: 7076015
    [Abstract] [Full Text] [Related]

  • 2. Treatment of radiolucent gallstones with CDCA or UDCA. A multicenter trial.
    Polli EE, Bianchi PA, Conte D, Sironi L.
    Digestion; 1981 May; 22(4):185-91. PubMed ID: 7030835
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution.
    Iwamura K.
    Hepatogastroenterology; 1980 Feb; 27(1):26-34. PubMed ID: 7203354
    [Abstract] [Full Text] [Related]

  • 6. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
    Leiss O, von Bergmann K.
    Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
    [Abstract] [Full Text] [Related]

  • 7. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K.
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [Abstract] [Full Text] [Related]

  • 8. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
    Podda M, Zuin M, Dioguardi ML, Festorazzi S, Dioguardi N.
    Hepatology; 1982 Nov; 2(3):334-9. PubMed ID: 7076116
    [Abstract] [Full Text] [Related]

  • 9. Kinetics of cholesterol gallstone dissolution by glycocheno-, glyco-ursodeoxycholic acid, and mixtures of both in vitro.
    Raedsch R, Stiehl A, Götz R, Walker S, Kommerell B.
    Z Gastroenterol; 1981 Apr; 19(4):159-63. PubMed ID: 7234028
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Faecal bile acid loss and bile acid pool size during short-term treatment with ursodeoxycholic and chenodeoxycholic acid in patients with radiolucent gallstones.
    Salvioli G, Salati R.
    Gut; 1979 Aug; 20(8):698-704. PubMed ID: 488763
    [Abstract] [Full Text] [Related]

  • 12. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
    Tint GS, Salen G, Shefer S.
    Gastroenterology; 1986 Oct; 91(4):1007-18. PubMed ID: 3527851
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of bile acid therapy for gallstone dissolution: a meta-analysis of randomized trials.
    May GR, Sutherland LR, Shaffer EA.
    Aliment Pharmacol Ther; 1993 Apr; 7(2):139-48. PubMed ID: 8485266
    [Abstract] [Full Text] [Related]

  • 14. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A, Raedsch R, Czygan P, Götz R, Männer C, Walker S, Kommerell B.
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [Abstract] [Full Text] [Related]

  • 15. [Dissolution of biliary calculi with CDCA and UDCA].
    Sugata F.
    Nihon Rinsho; 1984 Jul; 42(7):1683-9. PubMed ID: 6387220
    [No Abstract] [Full Text] [Related]

  • 16. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H, Roat JW, Gonzalez V, Sarva RP, Farivar S.
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [Abstract] [Full Text] [Related]

  • 17. [Combined therapy with chenodeoxycholic acid and ursodeoxycholic acid of radiolucent biliary lithiasis].
    Pérez Aguilar F, Breto M, del Val A, Berenguer J.
    An Med Interna; 1989 Mar; 6(3):119-24. PubMed ID: 2491184
    [Abstract] [Full Text] [Related]

  • 18. [Oral dissolving treatment of gallbladder calculi: focus in 1989].
    Erlinger S.
    Ann Chir; 1989 Mar; 43(6):417-9. PubMed ID: 2817740
    [Abstract] [Full Text] [Related]

  • 19. Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones.
    Zuin M, Petroni ML, Grandinetti G, Crosignani A, Bertolini E, Battezzati PM, Podda M.
    Scand J Gastroenterol; 1991 Mar; 26(3):257-62. PubMed ID: 1853147
    [Abstract] [Full Text] [Related]

  • 20. [Nucleation time and growth time in patients with cholesterol gallstone--factors affecting nucleation time and growth time and effect of UDCA and CDCA].
    Nomura Y.
    Nihon Shokakibyo Gakkai Zasshi; 1989 May; 86(5):1103-13. PubMed ID: 2795947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.